12127831

Insulin Management

PublishedOctober 29, 2024
Assigneenot available in USPTO data we have
Technical Abstract

Patent Claims
10 claims

Legal claims defining the scope of protection, as filed with the USPTO.

2

2. The computer-implemented method of claim 1, wherein receiving the sequential glucose measurements comprises receiving the sequential glucose measurements from an electronic medical record (EMR) system in communication with the data processing hardware.

3

3. The computer-implemented method of claim 1, wherein each of the sequential glucose measurements are measured by a continuous glucose monitoring system.

4

4. The computer-implemented method of claim 1, wherein determining the intravenous insulin infusion rate is further based on a constant K.

8

8. The computer-implemented method of claim 7, wherein the operations further comprise transmitting the revised total insulin rate to the insulin administration device, the revised total insulin rate when received by the insulin administration device, causing the insulin administration device to administer insulin to the patient using the revised total insulin rate.

9

9. The computer-implemented method of claim 1, wherein the operations further comprise displaying, in a graphical user interface displayed on a screen in communication with the data processing hardware, the total insulin rate.

11

11. The system of claim 10, wherein receiving the sequential glucose measurements comprises receiving the sequential glucose measurements from an electronic medical record (EMR) system in communication with the data processing hardware.

12

12. The system of claim 10, wherein each of the sequential glucose measurements are measured by a continuous glucose monitoring system.

13

13. The system of claim 10, wherein determining the intravenous insulin infusion rate is further based on a constant K.

17

17. The system of claim 16, wherein the operations further comprise transmitting the revised total insulin rate to the insulin administration device, the revised total insulin rate when received by the insulin administration device, causing the insulin administration device to administer insulin to the patient using the revised total insulin rate.

18

18. The system of claim 10, wherein the operations further comprise displaying, in a graphical user interface displayed on a screen in communication with the data processing hardware, the total insulin rate.

Patent Metadata

Filing Date

Unknown

Publication Date

October 29, 2024

Inventors

Robert C. Booth
Mr. Harry Hebblewhite

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “INSULIN MANAGEMENT” (12127831). https://patentable.app/patents/12127831

© 2026 Patentable. All rights reserved.

Patentable is a research and drafting-assistant tool, not a law firm, and does not provide legal advice. Documents we generate are drafts for review by a licensed patent attorney.

INSULIN MANAGEMENT — Robert C. Booth | Patentable